Drug Shortage Report for PMS-CIPROFLOXACIN XL

Last updated on 2024-07-10 History
Report ID 194525
Drug Identification Number 02416433
Brand name PMS-CIPROFLOXACIN XL
Common or Proper name CIPROFLOXACIN XL
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) CIPROFLOXACIN
Strength(s) 500MG
Dosage form(s) TABLET (IMMEDIATE AND EXTENDED RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-07-17
Actual start date
Estimated end date 2025-06-01
Actual end date
Shortage status Actual shortage
Updated date 2024-07-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-06-09 English Compare
v2 2023-06-09 French Compare
v3 2023-06-26 English Compare
v4 2023-06-26 French Compare
v5 2023-07-18 English Compare
v6 2023-09-18 English Compare
v7 2023-09-18 French Compare
v8 2023-12-27 English Compare
v9 2023-12-27 French Compare
v10 2024-03-15 English Compare
v11 2024-03-15 French Compare
v12 2024-04-29 English Compare
v13 2024-04-29 French Compare
v14 2024-05-10 English Compare
v15 2024-05-10 English Compare
v16 2024-05-10 French Compare
v17 2024-07-10 English Compare
v18 2024-07-10 French Compare

Showing 1 to 18 of 18